CAR-T cells can arm other immune cells to fight cancer, study says

But it's not yet known whether the mechanism could have a significant impact on the therapeutic efficacy of CAR-T

February 4, 2025 Check out STAT+

Sponsored By

On this World Cancer Day, get 50% off your first year of STAT+ for the latest news and analysis on cancer research. Thanks for reading and have a good Tuesday.

Adobe CAR-T cells can arm other immune cells with engineered proteins to fight cancer, study says Researchers found that bioengineered CAR-T cells when mixed with other immune cells can "donate" proteins, suggesting possible new avenues for therapies. By Angus Chen Opinion: HPV self-collection tests must be approved for use at home At-home HPV self-collection of samples is simple, efficient, and, for women familiar with using menstrual products, completely comfortable. By Emma McKim Mitchell and Christine Phelan Kueter Opinion: U.S. taxpayers should stop funding clinical trials of industry-owned drugs The current paradigm of government-funded cancer clinical trials — doing industry's work for it — is not working for taxpayers. By Mark J. Ratain David Dermer/AP He ruled the operating room and then daytime TV. Now, Dr. Oz is set to take over a $1.5 trillion health agency Sometimes dismissed as a "quack grifter" or "health care huckster," the surgeon turned daytime TV host has a large contingent of loyal supporters. By Tara Bannow

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser